|
361 |
Vorhofflimmern – Was ist bei chronischer Nierenerkrankung und Hämodialyse zu beachten? Enthalten in Deutsche medizinische Wochenschrift Bd. 149, 2024, Nr. 12: 724-727
|
|
|
362 |
Association between BMI and Efficacy of SGLT2 Inhibitors in Patients with Heart Failure or at Risk of Heart Failure: A Meta-Analysis Based on Randomized Controlled Trials Enthalten in Cardiology Bd. 149, 2024, Nr. 2: 104-116. 13 S.
|
|
|
363 |
Effectiveness of osteopathic manipulative applications on hypothalamic–pituitary–adrenal (HPA) axis in youth with major depressive disorder: a randomized double-blind, placebo-controlled trial Enthalten in Journal of osteopathic medicine Bd. 124, 2024, Nr. 6: 267-275. 09 S.
|
|
|
364 |
Elevated Insulin Levels Engage the Salience Network during Multisensory Perception Enthalten in Neuroendocrinology Bd. 114, 2024, Nr. 1: 90-106. 16 S.
|
|
|
365 |
Mirabegron Add-On Tamsulosin for Men with Overactive Bladder Symptoms: A Pooled Analysis of Four Randomized Controlled Trials Enthalten in Urologia internationalis Bd. 108, 2024, Nr. 2: 118-127. 10 S.
|
|
|
366 |
Efficacy of Donor-Recipient-Matched Faecal Microbiota Transplantation in Patients with IBS-D: A Single-Centre, Randomized, Double-Blind Placebo-Controlled Study Enthalten in Digestion Bd. 105, 2024, Nr. 6: 457-467. 11 S.
|
|
|
367 |
Randomized Controlled Trial of Remimazolam Compared with Placebo in Japanese Patients Undergoing Colonoscopy: A Phase III, Investigator-Initiated Trial Enthalten in Digestion Bd. 105, 2024, Nr. 6: 448-456. 9 S.
|
|
|
368 |
Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis Enthalten in Digestion Bd. 105, 2024, Nr. 3: 166-174. 9 S.
|
|
|
369 |
Effects of 5-Week Oral Acetazolamide on Incremental Cycling Exercise in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Randomized Placebo-Controlled, Double-Blinded, Crossover Trial Enthalten in Respiration Bd. 103, 2024, Nr. 3: 124-133. 10 S.
|
|
|
370 |
A Cohort Study of the Antitumor Efficacy and Toxicity Profile of Alpelisib for Metastatic or Locally Advanced HR+, HER2− Breast Cancer: A Single-Institution Experience Enthalten in Oncology Bd. 102, 2024, Nr. 5: 414-424. 11 S.
|
|